Latest Continuous Disclosure News

Insignia Financial has responded to ASX concerns over past disclosures of performance rights, affirming shareholder approvals and outlining improved compliance measures.

Riversgold Ltd has affirmed the material significance of its recent Northern Zone gold exploration results alongside a $2 million capital raising, assuring compliance with ASX continuous disclosure rules.

OZZ Resources has entered a binding option agreement with Scorpion Minerals to sell its Maguires Reward project, securing an initial $100,000 fee and potential $2.5 million consideration pending shareholder approval. Exploration activity remained subdued across its portfolio during the December quarter.

Codeifai Limited has responded to an ASX price query denying any undisclosed information behind recent unusual trading activity, while highlighting its nearing completion of the Antenna Transfer acquisition.

Helix Resources updates investors on the complex status of its Gold Basin joint venture amid a hostile takeover bid by Canex Metals and a loan restructuring by Gold Basin Resources.

Morella Corporation has initiated Federal Court proceedings against former receivers over disputed proceeds from a 2020 asset sale, aiming to recover value for shareholders without disrupting current operations.

Galileo Mining Ltd has responded to an ASX price and volume query, confirming no undisclosed material information exists to explain recent trading activity. The company attributes the surge to positive market sentiment around its Norseman Project and lithium joint venture with Mineral Resources.

Ryzon Materials will exit the ASX as it pursues a US exchange listing and prepares a fresh capital raise. The company remains focused on advancing its Nachu Graphite Project despite the transition.

Richmond Vanadium Technology Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity and attributing the surge to broader market interest and improved liquidity.

The a2 Milk Company has responded to an ASX price query denying any undisclosed information behind recent share price moves, attributing the volatility to China’s latest birth statistics.

Alice Queen Limited has addressed a recent doubling in its share price, attributing the surge to rising gold prices and ongoing project developments rather than undisclosed information.

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.